| #1 | | | Istanbul, Turkey | | 33+ years | Bacillus Calmette-Guérin (BCG) therapy, Immunotherapy with Keytruda (Pembolizumab), Immunotherapy for prostate cancer, Immunotherapy for lung cancer, Immunotherapy for breast cancer, Immunotherapy for kidney cancer, Sarcoma Immunotherapy | Patients needing personalized immunotherapy for various cancers | Anadolu Medical Center offers a wide range of immunotherapy treatments with experienced oncologists specializing in targeted therapies. Affiliated with Johns Hopkins Medicine and accredited by ESMO and JCI, ensuring high-quality care. | International Organization for Standardization, Joint Commission International |
| #2 | | | Istanbul, Turkey | | 17+ years | Immunotherapy with Keytruda (Pembrolizumab), CAR T-cell therapy | Advanced or metastatic cancers | Offers specialized immunotherapy treatments including Keytruda and CAR T-cell therapy. JCI and ISO accredited with a team of experienced oncologists. | Joint Commission International , International Organization for Standardization |
| #3 | | | Istanbul, Turkey | | 12+ years | Immunotherapy with Keytruda (Pembrolizumab), Immunotherapy for prostate cancer, Immunotherapy for lung cancer, Immunotherapy for breast cancer, Immunotherapy for kidney cancer | Personalized cancer care with immunotherapy | Specializes in tailored immunotherapy treatments with a multidisciplinary approach. Doctors have performed 900+ treatments with a focus on lung, breast, and gastrointestinal cancers. | Turkish Medical Association, International Health Tourism Authorization Certificate |
| #4 | | | Beijing, China | | 25+ years | Immunotherapy | — | — | — |
| #5 | | | Milan, Italy | | 57+ years8,000+ treatments | Immunotherapy with Keytruda (Pembolizumab), Immunotherapy for breast cancer, CAR T-cell therapy | Complex cancer cases | Multidisciplinary team including immunologists and oncologists. Specializes in personalized immunotherapy plans, including CAR T-cell therapy. Clinic performs over 52,000 operations annually. | Scientific Institute for Research and Healthcare Accrediatation, World's Best Hospitals 2021 by Newsweek |
| #6 | | | Barcelona, Spain | | 26+ years23,000+ treatments | Immunotherapy with Keytruda (Pembolizumab), CAR T-cell therapy, Immunotherapy for prostate cancer, Immunotherapy for lung cancer, Immunotherapy for breast cancer, Immunotherapy for kidney cancer, Sarcoma Immunotherapy | Multiple cancer types with tailored immunotherapy | Offers 10+ immuno-drugs for personalized treatment plans. JCI accredited with 95% patient recommendation rate. 1,100,000+ patients treated. | Joint Commission International , European Foundation for Quality Management |
| #7 | | | Vienna, Austria | | 44+ years | Immunotherapy for breast cancer, CAR T-cell therapy | Advanced or hard-to-treat cancers | Offers personalized immunotherapy treatments combined with targeted therapy and chemotherapy. Led by Prof. Christoph Zielinski, a global leader in cancer immunotherapy with over 600 published papers. 95% treatment success rate. | International Organization for Standardization, World's Best Hospitals 2021 by Newsweek |
| #8 | | | Istanbul, Turkey | | 25+ years | Biological therapy, Immunotherapy with Keytruda (Pembrolizumab), CAR T-cell therapy, Immunotherapy for prostate cancer, Immunotherapy for lung cancer, Immunotherapy for breast cancer, Immunotherapy for kidney cancer | Targeted cancer immunotherapy | Offers multiple immunotherapy options including Keytruda and CAR T-cell therapy. JCI-accredited with oncology department following international NCCN and ESMO protocols. Specializes in personalized immunotherapy based on genetic markers. | International Organization for Standardization, Joint Commission International |
| #9 | | | Tel Aviv, Israel | | 23+ years34,000+ treatments | Biological therapy, Immunotherapy with Keytruda (Pembolizumab), Immunotherapy for prostate cancer, Immunotherapy for lung cancer, Immunotherapy for breast cancer, Immunotherapy for kidney cancer, CAR T-cell therapy, Sarcoma Immunotherapy | Advanced or metastatic cancers | Offers a wide range of immunotherapy options, including CAR T-cell therapy and Keytruda. JCI accredited with a 90% success rate in cancer treatment. Research-focused team with access to clinical trials. | World's Best Smart Hospitals 2021 by Newsweek, World's Best Hospitals 2021 by Newsweek |
| #10 | | | Madrid, Spain | | 19+ years | CAR T-cell therapy | Melanoma and pediatric oncology cases | Provides access to latest immunodrugs and CAR T-cell therapy. Clinic conducts research in cancer treatment and offers participation in clinical trials. Recognized as one of the 'World's Best Hospitals 2021' by Newsweek. | World's Best Hospitals 2021 by Newsweek |